Copyright
©The Author(s) 2017.
World J Hepatol. Jan 28, 2017; 9(3): 131-138
Published online Jan 28, 2017. doi: 10.4254/wjh.v9.i3.131
Published online Jan 28, 2017. doi: 10.4254/wjh.v9.i3.131
Method1 | Mean estimated CrCl ± SD | Mean bias (mL/min) | ± 30% of measured CrCl | ± 50% of measured CrCl |
Measured CrCl | 109.5 ± 44.4 | |||
ActBW | 217 ± 113 | -107 | 13% | 30% |
IBW | 85 ± 29 | +24 | 48% | 89% |
AdjBW0.3 | 129 ± 55 | -20 | 54% | 76% |
AdjBW0.4 | 142 ± 63 | -33 | 52% | 67% |
FFW | 103 ± 48 | +7 | 61% | 83% |
LBW | 102 ± 43 | +8 | 56% | 87% |
MDRD4 | 96.3 ± 29.4 | +13.3 | 51.90% | 87% |
Salazar-Corcoran | 155.2 ± 65.1 | -45.7 | 46.20% | 55.60% |
- Citation: Scappaticci GB, Regal RE. Cockcroft-Gault revisited: New de-liver-ance on recommendations for use in cirrhosis. World J Hepatol 2017; 9(3): 131-138
- URL: https://www.wjgnet.com/1948-5182/full/v9/i3/131.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i3.131